Other versions:

(Verbatim name)

ID

(Catalog Number)

ORG

DES

Invalid DOI was provided, please try again

XML
PDF
Bluesky
Twitter
Facebook
Telegram
Mendeley
Reddit
Notify a colleague
  • ContentsContents
  • Article InfoArticle Info
  • CiteCite
  • MetricsMetrics
  • CommentComment
  • RelatedRelated
  • TabsTabs
  • RefsRefs
  • CitedCited
  • Article title
  • Graphical Abstract
  • Key words
  • 1. Introduction
  • 2. Mechanism of action of herpes virus-based oncolytics
  • 3. Oncolytic HSVs in melanoma treatment
    • 3.1. T-VEC in melanoma treatment
    • 3.2. RP1 in melanoma treatment
    • 3.3. Other herpes-based OV therapies in melanoma treatment
  • 4. Oncolytic HSVs in NMSC treatment
    • 4.1. T-VEC in NMSC treatment
    • 4.2. RP1 in NMSC treatment
    • 4.3. Other herpes-based OV therapies in NMSC treatment
  • 5. Summary, limitations and outlook
  • Additional information
    • Conflict of interest
    • Use of AI
    • Funding
    • Author contributions
    • Author ORCIDs
    • Data availability
  • References
Subscribe to email alerts for current Article's categories
Powered by